Annual Operating Profit
$20.63 M
+$213.47 M+110.70%
31 December 2023
Summary:
TG Therapeutics annual operaing income is currently $20.63 million, with the most recent change of +$213.47 million (+110.70%) on 31 December 2023. During the last 3 years, it has risen by +$294.23 million (+107.54%). TGTX annual operating profit is now at all-time high.TGTX Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Profit
$12.43 M
+$3.62 M+41.04%
30 September 2024
Summary:
TG Therapeutics quarterly operating income is currently $12.43 million, with the most recent change of +$3.62 million (+41.04%) on 30 September 2024. Over the past year, it has dropped by -$102.35 million (-89.17%). TGTX quarterly operating profit is now -89.17% below its all-time high of $114.78 million, reached on 30 September 2023.TGTX Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Operating Profit
-$505.00 K
-$102.35 M-100.50%
30 September 2024
Summary:
TG Therapeutics TTM operating income is currently -$505.00 thousand, with the most recent change of -$102.35 million (-100.50%) on 30 September 2024. Over the past year, it has increased by +$18.44 million (+97.33%). TGTX TTM operating profit is now -100.50% below its all-time high of $101.84 million, reached on 30 June 2024.TGTX TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TGTX Operating Profit Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +110.7% | -89.2% | +97.3% |
| 3 y3 years | +107.5% | +114.6% | +99.8% |
| 5 y5 years | +111.8% | +120.4% | +99.7% |
TGTX Operating Profit High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +106.0% | -89.2% | +113.4% | -100.5% | +99.8% |
| 5 y | 5 years | at high | +106.0% | -89.2% | +113.4% | -100.5% | +99.8% |
| alltime | all time | at high | +106.0% | -89.2% | +113.4% | -100.5% | +99.8% |
TG Therapeutics Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $12.43 M(+41.0%) | -$505.00 K(-100.5%) |
| June 2024 | - | $8.82 M(-195.1%) | $101.84 M(+110.6%) |
| Mar 2024 | - | -$9.27 M(-25.8%) | $48.35 M(+134.4%) |
| Dec 2023 | $20.63 M(-110.7%) | -$12.48 M(-110.9%) | $20.63 M(-208.9%) |
| Sept 2023 | - | $114.78 M(-356.9%) | -$18.94 M(-88.8%) |
| June 2023 | - | -$44.67 M(+20.8%) | -$168.69 M(+3.5%) |
| Mar 2023 | - | -$36.99 M(-28.9%) | -$162.96 M(-15.5%) |
| Dec 2022 | -$192.84 M(-44.1%) | -$52.06 M(+48.9%) | -$192.84 M(-17.5%) |
| Sept 2022 | - | -$34.96 M(-10.2%) | -$233.72 M(-17.7%) |
| June 2022 | - | -$38.94 M(-41.8%) | -$283.89 M(-12.0%) |
| Mar 2022 | - | -$66.87 M(-28.1%) | -$322.44 M(-6.5%) |
| Dec 2021 | -$344.77 M(+26.0%) | -$92.95 M(+9.2%) | -$344.77 M(+1.8%) |
| Sept 2021 | - | -$85.13 M(+9.9%) | -$338.60 M(-0.2%) |
| June 2021 | - | -$77.49 M(-13.1%) | -$339.20 M(+8.5%) |
| Mar 2021 | - | -$89.20 M(+2.8%) | -$312.55 M(+14.2%) |
| Dec 2020 | -$273.59 M(+61.8%) | -$86.78 M(+1.2%) | -$273.59 M(+21.7%) |
| Sept 2020 | - | -$85.72 M(+68.6%) | -$224.77 M(+12.4%) |
| June 2020 | - | -$50.84 M(+1.2%) | -$199.91 M(+8.3%) |
| Mar 2020 | - | -$50.24 M(+32.4%) | -$184.61 M(+9.2%) |
| Dec 2019 | -$169.06 M(-3.1%) | -$37.96 M(-37.6%) | -$169.06 M(-8.7%) |
| Sept 2019 | - | -$60.86 M(+71.2%) | -$185.24 M(+16.7%) |
| June 2019 | - | -$35.54 M(+2.5%) | -$158.71 M(-5.3%) |
| Mar 2019 | - | -$34.69 M(-35.9%) | -$167.51 M(-3.9%) |
| Dec 2018 | -$174.40 M(+46.9%) | -$54.15 M(+57.7%) | -$174.40 M(+15.3%) |
| Sept 2018 | - | -$34.33 M(-22.6%) | -$151.28 M(+1.8%) |
| June 2018 | - | -$44.34 M(+6.7%) | -$148.54 M(+12.0%) |
| Mar 2018 | - | -$41.58 M(+34.0%) | -$132.62 M(+11.7%) |
| Dec 2017 | -$118.71 M(+50.3%) | -$31.04 M(-1.7%) | -$118.71 M(+6.3%) |
| Sept 2017 | - | -$31.59 M(+11.1%) | -$111.70 M(+6.3%) |
| June 2017 | - | -$28.43 M(+2.7%) | -$105.04 M(+13.4%) |
| Mar 2017 | - | -$27.67 M(+15.1%) | -$92.64 M(+17.3%) |
| Dec 2016 | -$78.97 M(+25.0%) | -$24.03 M(-3.6%) | -$78.97 M(+8.8%) |
| Sept 2016 | - | -$24.93 M(+55.6%) | -$72.58 M(+18.1%) |
| June 2016 | - | -$16.02 M(+14.5%) | -$61.48 M(-1.7%) |
| Mar 2016 | - | -$13.99 M(-20.7%) | -$62.57 M(-1.0%) |
| Dec 2015 | -$63.18 M(+13.4%) | -$17.64 M(+27.6%) | -$63.18 M(-1.7%) |
| Sept 2015 | - | -$13.83 M(-19.2%) | -$64.26 M(-5.3%) |
| June 2015 | - | -$17.11 M(+17.2%) | -$67.87 M(+8.2%) |
| Mar 2015 | - | -$14.60 M(-22.0%) | -$62.72 M(+12.6%) |
| Dec 2014 | -$55.72 M(+176.3%) | -$18.72 M(+7.4%) | -$55.72 M(+32.1%) |
| Sept 2014 | - | -$17.44 M(+45.9%) | -$42.18 M(+43.5%) |
| June 2014 | - | -$11.96 M(+57.2%) | -$29.39 M(+22.1%) |
| Mar 2014 | - | -$7.61 M(+46.9%) | -$24.06 M(+19.3%) |
| Dec 2013 | -$20.17 M(-21.8%) | -$5.18 M(+11.4%) | -$20.17 M(+14.7%) |
| Sept 2013 | - | -$4.65 M(-29.9%) | -$17.58 M(+12.4%) |
| June 2013 | - | -$6.63 M(+78.5%) | -$15.64 M(+29.1%) |
| Mar 2013 | - | -$3.71 M(+43.6%) | -$12.12 M(-53.0%) |
| Dec 2012 | -$25.79 M(+2824.1%) | -$2.59 M(-4.7%) | -$25.79 M(+8.5%) |
| Sept 2012 | - | -$2.71 M(-12.6%) | -$23.76 M(+12.7%) |
| June 2012 | - | -$3.10 M(-82.1%) | -$21.08 M(+15.4%) |
| Mar 2012 | - | -$17.39 M(+3033.1%) | -$18.27 M(-4.6%) |
| Dec 2011 | -$882.00 K(-56.3%) | -$554.90 K(+1743.5%) | -$19.15 M(+0.6%) |
| Sept 2011 | - | -$30.10 K(-89.9%) | -$19.04 M(-2.5%) |
| June 2011 | - | -$297.00 K(-98.4%) | -$19.53 M(-1.2%) |
| Mar 2011 | - | -$18.27 M(+3990.3%) | -$19.75 M(+879.6%) |
| Dec 2010 | -$2.02 M | -$446.60 K(-13.4%) | -$2.02 M(+5.5%) |
| Sept 2010 | - | -$515.60 K(-1.8%) | -$1.91 M(+6.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2010 | - | -$525.10 K(-0.8%) | -$1.79 M(+2.7%) |
| Mar 2010 | - | -$529.40 K(+55.1%) | -$1.74 M(-1.6%) |
| Dec 2009 | -$1.77 M(-59.9%) | -$341.30 K(-13.7%) | -$1.77 M(+28.6%) |
| Sept 2009 | - | -$395.60 K(-17.1%) | -$1.38 M(-41.8%) |
| June 2009 | - | -$477.30 K(-14.4%) | -$2.37 M(-29.5%) |
| Mar 2009 | - | -$557.30 K(-1165.6%) | -$3.36 M(-23.9%) |
| Dec 2008 | -$4.41 M(-63.7%) | $52.30 K(-103.8%) | -$4.41 M(-30.9%) |
| Sept 2008 | - | -$1.38 M(-5.7%) | -$6.38 M(-17.2%) |
| June 2008 | - | -$1.47 M(-9.1%) | -$7.71 M(-31.0%) |
| Mar 2008 | - | -$1.61 M(-15.9%) | -$11.16 M(-8.1%) |
| Dec 2007 | -$12.14 M(+21.4%) | -$1.92 M(-29.1%) | -$12.14 M(-9.4%) |
| Sept 2007 | - | -$2.71 M(-45.0%) | -$13.41 M(+5.9%) |
| June 2007 | - | -$4.92 M(+89.8%) | -$12.66 M(+25.4%) |
| Mar 2007 | - | -$2.59 M(-18.4%) | -$10.10 M(+1.0%) |
| Dec 2006 | -$10.00 M(-48.3%) | -$3.18 M(+61.8%) | -$10.00 M(-53.2%) |
| Sept 2006 | - | -$1.97 M(-16.6%) | -$21.35 M(+0.5%) |
| June 2006 | - | -$2.36 M(-5.6%) | -$21.24 M(+4.2%) |
| Mar 2006 | - | -$2.50 M(-82.8%) | -$20.40 M(+5.4%) |
| Dec 2005 | -$19.36 M(+215.1%) | -$14.53 M(+680.4%) | -$19.36 M(+192.3%) |
| Sept 2005 | - | -$1.86 M(+23.3%) | -$6.62 M(-5.4%) |
| June 2005 | - | -$1.51 M(+3.6%) | -$7.00 M(+8.1%) |
| Mar 2005 | - | -$1.46 M(-18.7%) | -$6.48 M(+5.5%) |
| Dec 2004 | -$6.14 M(+29.1%) | -$1.79 M(-20.1%) | -$6.14 M(+4.6%) |
| Sept 2004 | - | -$2.24 M(+127.2%) | -$5.87 M(+3.6%) |
| June 2004 | - | -$986.70 K(-12.1%) | -$5.67 M(+3.8%) |
| Mar 2004 | - | -$1.12 M(-26.2%) | -$5.46 M(+14.7%) |
| Dec 2003 | -$4.76 M(+367.3%) | -$1.52 M(-25.4%) | -$4.76 M(+55.0%) |
| Sept 2003 | - | -$2.04 M(+162.4%) | -$3.07 M(+89.6%) |
| June 2003 | - | -$777.00 K(+84.0%) | -$1.62 M(+48.4%) |
| Mar 2003 | - | -$422.20 K(-350.9%) | -$1.09 M(-16.0%) |
| Dec 2002 | -$1.02 M(-67.2%) | $168.30 K(-128.6%) | -$1.30 M(-35.9%) |
| Sept 2002 | - | -$588.20 K(+136.4%) | -$2.02 M(-5.4%) |
| June 2002 | - | -$248.80 K(-60.5%) | -$2.14 M(-36.4%) |
| Mar 2002 | - | -$629.60 K(+12.8%) | -$3.37 M(+13.7%) |
| Dec 2001 | -$3.11 M(-1.7%) | -$558.20 K(-20.8%) | -$2.96 M(+3382.8%) |
| Sept 2001 | - | -$704.50 K(-52.2%) | -$85.00 K(-75.3%) |
| June 2001 | - | -$1.47 M(+556.6%) | -$344.00 K(-82.5%) |
| Mar 2001 | - | -$224.40 K(-109.7%) | -$1.97 M(-37.4%) |
| Dec 2000 | -$3.16 M(+17.1%) | $2.32 M(-340.5%) | -$3.15 M(-48.1%) |
| Sept 2000 | - | -$963.50 K(-68.9%) | -$6.06 M(+8.3%) |
| June 2000 | - | -$3.10 M(+120.8%) | -$5.60 M(+74.9%) |
| Mar 2000 | - | -$1.40 M(+133.8%) | -$3.20 M(+14.4%) |
| Dec 1999 | -$2.70 M(-15.6%) | -$600.00 K(+20.0%) | -$2.80 M(-22.2%) |
| Sept 1999 | - | -$500.00 K(-28.6%) | -$3.60 M(-16.3%) |
| June 1999 | - | -$700.00 K(-30.0%) | -$4.30 M(+53.6%) |
| Mar 1999 | - | -$1.00 M(-28.6%) | -$2.80 M(-9.7%) |
| Dec 1998 | -$3.20 M(-39.6%) | -$1.40 M(+16.7%) | -$3.10 M(-6.1%) |
| Sept 1998 | - | -$1.20 M(-250.0%) | -$3.30 M(+6.5%) |
| June 1998 | - | $800.00 K(-161.5%) | -$3.10 M(-44.6%) |
| Mar 1998 | - | -$1.30 M(-18.8%) | -$5.60 M(+9.8%) |
| Dec 1997 | -$5.30 M(+43.2%) | -$1.60 M(+60.0%) | -$5.10 M(+10.9%) |
| Sept 1997 | - | -$1.00 M(-41.2%) | -$4.60 M(-2.1%) |
| June 1997 | - | -$1.70 M(+112.5%) | -$4.70 M(+30.6%) |
| Mar 1997 | - | -$800.00 K(-27.3%) | -$3.60 M(+33.3%) |
| Dec 1996 | -$3.70 M | -$1.10 M(0.0%) | -$2.70 M(+68.8%) |
| Sept 1996 | - | -$1.10 M(+83.3%) | -$1.60 M(+220.0%) |
| June 1996 | - | -$600.00 K(-700.0%) | -$500.00 K(-600.0%) |
| Mar 1996 | - | $100.00 K | $100.00 K |
FAQ
- What is TG Therapeutics annual operaing income?
- What is the all time high annual operating profit for TG Therapeutics?
- What is TG Therapeutics annual operating profit year-on-year change?
- What is TG Therapeutics quarterly operating income?
- What is the all time high quarterly operating profit for TG Therapeutics?
- What is TG Therapeutics quarterly operating profit year-on-year change?
- What is TG Therapeutics TTM operating income?
- What is the all time high TTM operating profit for TG Therapeutics?
- What is TG Therapeutics TTM operating profit year-on-year change?
What is TG Therapeutics annual operaing income?
The current annual operating profit of TGTX is $20.63 M
What is the all time high annual operating profit for TG Therapeutics?
TG Therapeutics all-time high annual operaing income is $20.63 M
What is TG Therapeutics annual operating profit year-on-year change?
Over the past year, TGTX annual operaing income has changed by +$213.47 M (+110.70%)
What is TG Therapeutics quarterly operating income?
The current quarterly operating profit of TGTX is $12.43 M
What is the all time high quarterly operating profit for TG Therapeutics?
TG Therapeutics all-time high quarterly operating income is $114.78 M
What is TG Therapeutics quarterly operating profit year-on-year change?
Over the past year, TGTX quarterly operating income has changed by -$102.35 M (-89.17%)
What is TG Therapeutics TTM operating income?
The current TTM operating profit of TGTX is -$505.00 K
What is the all time high TTM operating profit for TG Therapeutics?
TG Therapeutics all-time high TTM operating income is $101.84 M
What is TG Therapeutics TTM operating profit year-on-year change?
Over the past year, TGTX TTM operating income has changed by +$18.44 M (+97.33%)